由Micrococcus antarcticus引起的社区肺炎:一个罕见的病例报告
Jia Xu1,2, Yingmiao Zhang2, Lifeng Shi2
1School of Laboratory Medicine, Hubei University of Chinese Medicine, Wuhan, China.
BMC infectious diseases
|October 25, 2024
概括
以前被认为是非致病的南极菌 (Micrococcus antarcticus) 在一位老年妇女身上引起了社区获得性肺炎 (CAP). 这是有史以来首次报告的人类感染,突出显示了这种细菌.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 临床医学 临床医学
背景情况:
- 南极菌 (Micrococcus antarcticus) 是一种从南极洲分离出来的有氧性格拉姆阳性细菌.
- 以前被认为具有低致病性,没有报告的人类感染.
- 这项研究报告了第一例由M. antarcticus引起的社区获得性肺炎 (CAP).
研究的目的:
- 描述了第一次报告的人类感染Micrococcus antarcticus的病例.
- 突出M. antarcticus作为社区获得性肺炎的潜在病原体.
- 为了告知临床医生关于M. antarcticus.的致病性.
主要方法:
- 一个87岁的女性患者的案例研究,呈现出肺炎症状.
- 使用MALDI-TOF MS和16S rRNA基因测序从支气管洗液中识别M. antarcticus.
- 基于临床表现,实验室结果和成像,诊断CAP,然后进行抗生素治疗.
主要成果:
- M. antarcticus被确定为该患者中CAP的致病原体.
- 患者接受了塞福拉/苏尔巴克坦和勒沃素,导致临床改善.
- 患者被释放,在5个月的随访期间没有出现异常.
结论:
- 南极球菌 (Micrococcus antarcticus) 是一种极其罕见但潜在的病原体,能够引起社区获得的肺炎.
- 这一案例强调了在CAP的差异诊断中考虑M. antarcticus的重要性.
- 对M. antarcticus作为病原体的认识对于准确诊断和有效治疗肺炎至关重要.
更多相关视频
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
15.0K
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
11.7K
相关概念视频
01:30Pneumonia I: Introduction
211
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
211
01:30Pneumonia III: Complications and Assessment
174
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
174
01:28Pneumonia IV: Management
302
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
302
01:29Pneumonia II: Pathophysiology
225
The pathophysiology of pneumonia involves the following steps:
225